Drugs / Grass pollen extract
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01982474 | Oct 2013 → Dec 2016 | allergic rhinitis | Amber Patterson | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00470457 | Jun 2001 → Mar 2005 | seasonal allergic rhinitis | University of Zurich | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | grass pollen extract | “intralymphatic immunotherapy (ILIT) with 3 low dose grass pollen extract injections over 2 months” NCT00470457 ↗ |
| Route | Other | “intralymphatic immunotherapy (ILIT) with 3 low dose grass pollen extract injections over 2 months” NCT00470457 ↗ |